← Eichor
Study identifier: NCT05526963 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Reduction of Polypharmacy in Elderly People With Multiple Diseases

Condition: Polypharmacy · Multimorbidity  ·  Sponsor: Martin-Luther-Universität Halle-Wittenberg

PhaseNA
Planned participants1146
Who can joinAll sexes, 70 Years to no upper limit
Healthy volunteersNo

About this study

Elderly GP patients are often treated with five or more medications and therefore prone to adverse drug reactions (ADR). Potentially inappropriate prescriptions (PIPs) lead to increased adverse events like falls, hospitalizations and mortality. The primary aim of this study to reduce the frequency of ADRs in multimorbid patients aged 70 years and older by reducing polypharmacy.

This description comes directly from the study's public registry record.

Talk to the study team

Alexander Bauer, Dr.  ·  +493455575338  ·  raphael@uk-halle.de

Always discuss trial participation with your own doctor first.

Locations (1)

HAP ANZHalle, Saxony-Anhalt, GermanyRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05526963